Using latent class and quantum models to value equity in health care: A tale of 2 stories

Cost-effectiveness analysis (CEA) with quality-adjusted life-year (QALY) was introduced to address health equity concerns in value assessment. However, QALY fails to capture patient preference. Stated preference methods (eg, discrete choice experiment [DCE]) have been increasingly used to incorporat...

Full description

Bibliographic Details
Main Author: Ngorsuraches, S. (Author)
Format: Article
Language:English
Published: Academy of Managed Care Pharmacy (AMCP) 2021
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02641nam a2200457Ia 4500
001 10.18553-JMCP.2021.27.9-A.S12
008 220427s2021 CNT 000 0 und d
020 |a 23760540 (ISSN) 
245 1 0 |a Using latent class and quantum models to value equity in health care: A tale of 2 stories 
260 0 |b Academy of Managed Care Pharmacy (AMCP)  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.18553/JMCP.2021.27.9-A.S12 
520 3 |a Cost-effectiveness analysis (CEA) with quality-adjusted life-year (QALY) was introduced to address health equity concerns in value assessment. However, QALY fails to capture patient preference. Stated preference methods (eg, discrete choice experiment [DCE]) have been increasingly used to incorporate patient preference into the value assessment framework in health care. Still, ones with a moral dimension such as health equity do not exist. The objective of this paper was to describe 2 stated preference approaches that can empirically value health equity. First, the decision-maker perceptions of the prevalence of equity dimensions in DCE choice tasks are identified. A latent class model based on random utility theory is proposed to derive the value of equity from the decision makers with different perceptions of the prevalence of equity dimensions. Second, equity attributes are incorporated in DCE choice tasks, and a quantum choice model, which can capture stochasticity during the decision process in the mind of the decision makers, is used to value the equity. These approaches will improve existing value assessment methods to address health equity adequately. Copyright©2021, Academy of Managed Care Pharmacy. All rights reserved. 
650 0 4 |a article 
650 0 4 |a Choice Behavior 
650 0 4 |a cost benefit analysis 
650 0 4 |a Cost-Benefit Analysis 
650 0 4 |a decision making 
650 0 4 |a Delivery of Health Care 
650 0 4 |a funding 
650 0 4 |a health care delivery 
650 0 4 |a health equity 
650 0 4 |a health equity 
650 0 4 |a Health Equity 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Models, Theoretical 
650 0 4 |a morality 
650 0 4 |a patient preference 
650 0 4 |a Patient Preference 
650 0 4 |a perception 
650 0 4 |a prevalence 
650 0 4 |a purchasing 
650 0 4 |a quality adjusted life year 
650 0 4 |a Quality-Adjusted Life Years 
650 0 4 |a stochastic model 
650 0 4 |a theoretical model 
650 0 4 |a theoretical study 
650 0 4 |a Utah 
650 0 4 |a Value-Based Purchasing 
700 1 |a Ngorsuraches, S.  |e author 
773 |t Journal of Managed Care and Specialty Pharmacy